Is There a Way to Reduce the Need for Permanent Pacemaker Implantation in Self-Expanding Valves?

We are well aware of the benefits of TAVR in different scenarios, but the need for permanent pacemaker implantation (PPI) in self-expandable valves is between 15% and 30% according to different randomized and non-randomized studies.

¿Cómo podemos disminuir la necesidad de implante de marcapasos definitivo en las válvulas autoexpandibles?

This is why the higher implantation strategy or cusp overlap (COT) was developed and, though it has been shown to significantly reduce the need for PPI, so far, no randomized studies have looked into it. 

This study included 2209 patients with severe symptomatic aortic stenosis receiving self-expandable supra-annular valves from Medtronic (Evolut R, Evolute Pro and Evolute Pro+). 1151 of these patients were treated with the standard three-cusp implantation technique (3CT) (52.1%) and 1058 with the COT strategy.

Primary end point was need for PPI at discharge. 

Mean age was 82 and 54% of the population were women. After propensity score matching to balance for differences, 995 patients were left in each group. 

STS score was 3.6%, 96% was femoral, 91% under conscious sedation.

Read also: Drug-Eluting Balloon in STEACS: Leaving No Trace is Beneficial?

Procedural time was lower with COT, as was fluoroscopy time.

Pre and post-dilation were more frequent with COT, as was oversizing. Contrast volume was lower with COT.

PPI resulted in favor of COT in both the general and the matched population, 12.3% vs. 17% p=0.002 and 11.9% vs 17% p=0.001 respectively. New left bundle branch block was more frequent with COT (27.5% vs 22.6% p=0.01), and there were no differences in right bundle branch block. 

There were no differences in major complications.

Read also: Benefits of Distal Radial Access.

Severe and moderate paravalvular regurgitation were significantly lower in patients treated with COT (4.6% vs. 2.4% p=0.006).

In multivariable logistic regression, right bundle branch block and diabetes resulted predictors of PPI and COT resulted protective. 

Conclusion

COT was associated with significant reduction of PPI and paravalvular regurgitation with no increase in complications. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Cusp overlap versus standard three-cusp technique for selfexpanding Evolut transcatheter aortic valves.

Reference: Hendrik Wienemann, et al.  EuroIntervention 2023;18-online publish-ahead-of-print April 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....